CHOLESTEROL TRIGLYCERIDES AND THEIR RELATION SHIP DIABETES
Abstract
This study composes two parts:
First: The importance of the research:
Attention is drawn to the fact that diabetics do not only need drug treatment, but rather other factors that help them to continue compatibility with the disease and its complications, such as: ego strength. The environment surrounding the patient, and a diet. The importance of the study in terms of dealing with diabetes and its health and psychological danger to patients in the current era (the sixth disease in the world in terms of mortality rate).
The importance of the study in terms of addressing an interventional method to improve the level of diabetes, fat and cholesterol in diabetics by applying some treatment Background: Previous studies have suggested that elevated triglyceride levels may precede the appearance of glucose metabolic disturbances in adults; nonetheless, this hypothesis has not been tested in children. Hence, we evaluated whether hypertriglyceridemia is associated with impaired fasting glucose (IFG) in normal-weight children
Second: the research problem:
A person in his life is not free from maladjustment, as a person is exposed throughout his life to many physical and psychological pressures and problems that affect his compatibility process, such as his exposure to chronic psychological or physical diseases. Where the individual needs to make more effort to reach a state of full compatibility, and among these diseases, diabetes, and this study deals with diabetes as a chronic disease that the sufferer needs to be able to adapt in his daily life, knowing that this disease is common, and results in acute and chronic symptoms and complications in different body systems, and it may affect the patient’s psychological state and other diseases such as high fat and cholesterol. Diabetes is one of the psychosomal disorders that have high rates among different groups of society, and its prevalence increases with age, especially among males.
References
1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl 5): S7–S85.
2. Garcia MJ, McNamara PM, Gordon T, Kanal WB. Morbidity and Mortality in diabetes in the Framingham population. Diabetes 1974; 23: 105–11.
3. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in national sample. Am J Epidemiol 1988; 128: 389– 401.
4. Krolewski S, Czyzyk A., Janeczko D, Kopczynski J. Mortality from Cardiovascular Diseases among diabetics. Diabetologia 1977; 13: 345–50.
5. Fava S, Azzopardi J, Muscat HA, Fenech FF. Factors that influence the outcome in diabetic patients with myocardial infarction. Diabetes Care 1993; 16:
6. Herlitz J, Karlson BW, Edvardsson N, Emanuelsson H, Hjalmarson A. 1615–8. Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction. Cardiology 1992; 80: 237–45.
7. Hulley SB. The associations between triglyceride and coronary heart disease. N Engl J Med 1980; 302: 1383–9.
8. Jeppesen J, Hein H, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998; 97: 1029–36.
9. Cowie CC, Harris MI. Physical and metabolic characteristics of persons with diabetes. Diabetes in America. 2nd ed. National Institutes of Health 1995; 117–64.
10. Patti L, Di Marino L, Maffettone A, Roamno G, Annuzzi G, Riccardi G, Rivellese AA. Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose
11. Nettina, s. (1996). Manual of Nursing Practice. 6th edition, Lippincott Company, New York.
12. Ali, Mamdouh Mukhtar. (2001). Behavioral therapy as a containment and treatment mechanism for mental disorders associated with diabetes in light of some personality variables. Unpublished PhD thesis, Department of Psychology, Faculty of Arts, Tanta University, Egypt.
13. Polonovski, J. (2000). Dictionaries De Biology. Edition CILF, Paris, 238- 239.
14. Pickles, Jalal. (1984). Nutrition and human health. Publications of the Islamic University, Gaza.
15. Annual Report. (2005). the Status of Health in Palestine. Ministry of Health, Gaza, Palestine.
16. Rouiha, Amin. (1973). Diabetes mellitus, its symptoms, causes and ways to combat it. Beirut: Dar Al-Qalam.
17. Clark, Marjoret. (1963). modern medicine. Translated by Muhammad Nazif, Cairo: The House of Arab Thought.
18. Radwan, Abdul Karim. (2002b). Anxiety among diabetics in Gaza Governorate and its relationship to some variables. Unpublished MA Thesis, Deanship of Postgraduate Studies, Islamic University, Gaza, Palestine.
19. Rouiha, Amin. (1973). Diabetes mellitus, its symptoms, causes and ways to combat it. Beirut: Dar Al-Qalam.
20. The past, Muhammad. (1998). Sugar is a sworn friend. Cairo: Dar El-Nasr for printing.
21. Moqbel, Mervat Abed Rabbo. (2010). Psychological compatibility and its relationship to ego power and some variables among diabetics in the Gaza Strip. Unpublished MA Thesis, College of Education, Islamic University, Gaza.
22. Al-Bakiri, Abdullah. (1994). Food and Community Health, Arab Education Office, Riyadh, Saudi Arabia.
23. Al-Homsi, Essam. (1985). The Concise Medical Encyclopedia. Damascus: Publishing House.Hashem, Muhammad. Pasha, Wael. (1990). Endocrine and metabolic diseases. Part 6, Damascus: Al-Amani Press.
24. Heaven is educating patients and their families. (2013). What is diabetes ?. Endocrinology and Diabetes Unit, Hamad Medical Corporation "Health, Education, Research", Qatar, p. P: 10-383.
25. Lewis, S., Weilitz, P., Collier, I. (2004). Medical Surgical Nursing. Sixth Edition, Mosby Company, U.S.A.
26. Al-Hamid, Muhammad bin Saad. (2007). Diabetes: its causes, complications and treatment. Riyadh: Arab Science House.
27. Wafa, Mohamed Zafer. (2005). Diabetes prevention and treatment. Beirut: Home of Science for the Millions.
28. Radwan, Abdul Karim. (2008). The effectiveness of a training counseling program to reduce psychological pressure and improve compatibility among diabetic patients in Gaza Governorate. Unpublished PhD thesis, Deanship of Postgraduate Studies, Islamic University, Gaza.
29. Al-Zatma, Adnan. (1985). Diabetes, the modern view of its treatment and its complications. ”Unpublished Master Thesis, Faculty of Education, University of Damascus.
30. Granny, perfect. Yunus, Ibrahim. (1993). The guide for diabetic patients. Gaza: Health Services Council.
31. Marion, J. (1999). Standard of Medical Care for Patients with Diabetes
32. Siu, S., KW Wong, SK. , YS Wong, KM. (2001). Prevalence and Risk Factors for Erectile Dysfunction in Hong Kong Diabetic Patients. Diabetes U.K, vol.18, p.p: 732-738
33. Rubin, R. & Peyrot, M. (1998). Men and Diabetes Psychosocial and Behavioral Issues. Diabetes Spectrum Journal, vol. 11, No. 2, p. p: 81-87.
34. Richard, S. (1995). The Joslin Guide to Diabetes. Program for Management your Treatment, Afirsid book, New York.
35. "Nomenclature of Lipids". IUPAC-IUB Commission on Biochemical Nomenclature (CBN). Retrieved 2007-03-08.
36. Nelson, D. L.; Cox, M. M. (2000). Lehninger, Principles of Biochemistry (3rd ed.). New York: Worth Publishing. ISBN 1- 57259-153-6.
37. Lampe, M. A.; Burlingame, A. L.; Whitney, J.; Williams, M. L.; Brown, B. E.; Roitman, E.; Elias, M. (1983). "Human stratum corneum lipids: characterization and regional variations". J.Lipid Res. 24 (2): 120–130. PMID 6833889.
38. a b c Alfred Thomas (2002). "Fats and Fatty Oils". Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a10_173. ISBN 3527306730.
39. Charbonnet, G. H.; Singleton, W. S. (1947). "Thermal properties of fats and oils". J. Am. Oil Chem. Soc. 24 (5): 140. doi:10.1007/BF02643296. 6. ^ Lok, C.M.; Ward, J.P.; van Dorp, D.A. (1976). "The synthesis of Chiral Glycerides starting from D- and L-serine". Chemistry and Physics of Lipids. 1 (2): 115–122. doi:10.1016/0009- 3084(76)90003-7. PMID 1269065.
40. White, Hayden; Venkatesh, Balasubramanian (2011). "Clinical review: Ketones and brain injury". Critical Care. 15 (2): 219. doi:10.1186/cc10020. PMC 3219306. PMID 21489321.
41. a b Drummond, K. E.; Brefere, L. M. (2014). Nutrition for Foodservice and Culinary Professionals (8th ed.). John Wiley & Sons. ISBN 978-0-470-05242-6.
42. "Boston scientists say triglycerides play key role in heart health". The Boston Globe. Retrieved 2014-06-18.
43. Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN (2017). "Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases". Oxidative Medicine and Cellular Longevity. 2017: 1273042 doi:10.1155/2017/1273042. PMC 5441126. PMID 2857 2872.
44. "Triglycerides". MedlinePlus. Archived from the original on 26 October 2012. Retrieved 2015-04-23.
45. Crawford, H., Micheal. Current Diagnosis & Treatment Cardiology. 3rd ed. McGraw-Hill Medical, 2009. p19
46. "What's considered normal?". Triglycerides: Why do they matter?. Mayo Clinic. 28 September 2012.
47. a b Nordestgaard, BG; Varbo, A (August 2014). "Triglycerides and cardiovascular disease". The Lancet. 384 (9943): 626–35. doi:10.1016/S0140- 6736(14)61177-6. PMID 25131982.
48. GILL, Jason; Sara HERD; Natassa TSETSONIS; Adrianne HARDMAN (Feb 2002). "Are the reductions in triacylglycerol and insulin levels after exercise related?". Clinical Science. 102 (2): 223–231. doi:10.1042/cs20010204. PMID 11834142. Retrieved 2 March 2013.
49. a b Crawford, H., Micheal. Current Diagnosis & Treatment Cardiology. 3rd ed. McGraw-Hill Medical, 2009. p21
50. a b c Berglund L, Brunzell JD, Goldberg AC, et al. (September 2012). "Evaluation and treatment of hypertriglyceridemia: an endocrine society clinical practice guideline". J. Clin. Endocrinol. Metab. 97 (9): 2969– 89 doi:10.1210/jc.2011-3213. PMC 3431581. PMID 22962670.
51. High blood triglycerides. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/highblood- triglycerides. Accessed Aug. 7, 2018.
52. Bonow RO, et al., eds. Risk markers and the primary prevention of cardiovascular disease. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, Pa.: Saunders Elsevier; 2019. https://www.clinicalkey.com. Accessed May 30, 2018.
53. Kumar P, et al., eds. Lipid and metabolic disorders. In: Kumar and Clark's Clinical Medicine. 9th ed. Philadelphia, Pa.: Elsevier; 2017. https://clinicalkey.com. Accessed May 22, 2018.
54. AskMayoExpert. Triglycerides (adults). Rochester, Minn.: MayoFoundation for Medical Education and Research; 2018.
55. AskMayoExpert. Hyperlipidemia (adult). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2018.
57. http://www.webmd.com/a-to-z-guides/condition-15/diabetes/cholesterol-tests
58. American Heart Association [Internet]. Dallas (TX): American Heart Association Inc.; c2017. About Cholesterol; [updated 2016 Aug 10; cited 2017 Feb 6]; [about 3screens]. Available from: http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/About Cholesterol_UCM_001220_Article.jsp
59. American Heart Association [Internet]. Dallas (TX): American Heart Association Inc.; c2017. Good vs. Bad Cholesterol; [updated 2017 Jan 10; cited 2017 Jan 26]; [about 3 screens]. Available from: http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/Goo d-vs-Bad-Cholesterol_UCM_305561_Article.jsp
60. American Heart Association [Internet]. Dallas (TX): American Heart Association Inc.; c2017. How To Get Your Cholesterol Tested; [updated 2016 Mar 28; cited 2017 Jan 26]; [about 3screens]. Available from: http://www.heart.org/HEARTORG/Conditions/Cholesterol/SymptomsDiagnosisMonitoringofHighCholesterol/How-To-Get-Your-Cholesterol Tested_UCM_305595_Article.jsp
61. American Heart Association [Internet]. Dallas (TX): American Heart Association Inc.; c2017. Prevention and Treatment of High Cholesterol; [updated 2016 Aug 30; cited 2017 Jan 26]; [about 7 screens]. Available from: http://www.heart.org/HEARTORG/Conditions/Cholesterol/PreventionTreatment of High Cholesterol /Prevention-and-Treatment-of-High Cholesterol_UCM_001215_Article.jsp
62. American Heart Association [Internet]. Dallas (TX): American Heart Association Inc.; c2017. What Your Cholesterol Levels Mean; [updated 2016 Aug
63. cited 2017 Jan 26]; [about 3 screens]. Available from: http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/Wha t-Your-Cholesterol-Levels-Mean_UCM_305562_Article.jsp
64. FDA: US Food and Drug Administration [Internet]. Silver Spring (MD): U.S. Department of Health and Human Services; Cholesterol; [updated 2018 Feb 6; cited 2019 Jan 25]; [about 4 screens]. Available from: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/HomeUseTests/ucm125686.htm
65. Healthfinder.gov. [Internet]. Washington D.C.: Office of Disease Prevention and Health Promotion; National Health Information Center; Get Your Cholesterol Checked; [updated 2017 Jan 4; cited 2017 Jan 26]; [about 4 screens]. Available from: https://healthfinder.gov/healthtopics/dispatch.aspx?q1=doctorvisits&q2;=screening-tests&q3;=get-your-cholesterol-checked
66. Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research; c1998-2017.Cholesterol Test: Overview; 2016 Jan 12 [cited 2017 Jan 26]; [about 3 screens]. Available from: http://www.mayoclinic.org/tests procedures/cholesteroltest/home/ovc-20169526
67. Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research; c1998-2017.Cholesterol Test: What you can expect; 2016 Jan 12 [cited 2017 Jan 26]; [about 6 screens]. Available from: http://www.mayoclinic.org/testsprocedures/cholesterol-test/details/what-you-can-expect/rec-20169541 8
68. Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research; c1998-2017. Cholesterol Test: Why it's done; 2016 Jan 12 [cited 2017 Jan 26]; [about 4 screens]. Available from: http://www.mayoclinic.org/tests procedures/cholesterol-test/details/why-its-done/icc-20169529
69. Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research; c1998-2017.High Cholesterol: Overview 2016 Feb 9 [cited 2017 Jan 26]; [about 3 screens]. Available from: http://www.mayoclinic.org/diseases-conditions/highblood-cholesterol/home/ovc-20181871
70. Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research; c1998-2017.VLDL cholesterol: Is it harmful? [cited 2017 Jan 26]; [about 3 screens]. Available from: http://www.mayoclinic.org/diseases-conditions/highblood-cholesterol/expert-answers/vldl-cholesterol/faq-20058275
71. National Heart, Lung, and Blood Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; High Blood Cholesterol: What You Need to Know; 2001 May [updated 2005 Jun; cited 2017 Jan 26]; [about 5 screens]. Available from: https://www.nhlbi.nih.gov/health/resources/heart/heartcholesterol-hbc-what-html
72. National Heart, Lung, and Blood Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; How is High Blood Cholesterol Diagnosed? 2001 May [updated 2016 Apr 8; cited 2017 Jan 26]; [about 5 screens]. Available from: https://www.nhlbi.nih.gov/health/healthtopics/topics/hbc/diagnosis
73. National Heart, Lung, and Blood Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; What Are the Risks of Blood Tests? [updated 2012 Jan 6; cited 2017 Jan 26]; [about 5 screens. Available from: https://www.nhlbi.nih.gov/health/health-topics/topics/bdt/risks
74. National Heart, Lung, and Blood Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; What is Cholesterol? [cited 2017 Jan 26]; [about 4 screens]. Available from: https://www.nhlbi.nih.gov/health/healthtopics/topics/hbc
75. National Heart, Lung, and Blood Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; What To Expect with Blood Tests; [updated 2012 Jan 6; cited 2017 Jan 25]; [about 5 screens].Available from: https://www.nhlbi.nih.gov/health/health-topics/topics/bdt/with
76. Quest Diagnostics [Internet].Quest Diagnostics; c2000-2017. Test Center: LDL Cholesterol; [updated 2012 Dec; cited 2017 Jan 26]; [about 3 screens]. Available from: https://www.questdiagnostics.com/testcenter/TestDetail.action?ntc=8293
77. American Diabetes Association. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S111-S134. PMID: 31862753 www.ncbi.nlm.nih.gov/pubmed/31862753.
78. Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation. 2015;132(8):691-718. PMID: 26246173 www.ncbi.nlm.nih.gov/pubmed/26246173.
79. Gennest J, Libby P. Lipoprotein disorders and cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier; 2019:chap 48. 9
80. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350.2018. PMID: 30423393 www.ncbi.nlm.nih.gov/pubmed/30423393.
81. Rohatgi A. Lipid measurement. In: de Lemos JA, Omland T, eds. Chronic Coronary Artery Disease: A Companion to Braunwald's Heart Disease. Philadelphia, PA: Elsevier; 2018:chap 8.
